Detailed price information for Genscript Biotech Corp (GNNSF) from The Globe and Mail including charting and trades.
Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond "The conversations throughout the day reinforced that ...
PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of ...
The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D ...
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, ...
The average one-year price target for Genscript Biotech (OTCPK:GNNSF) has been revised to $3.32 / share. This is an increase of 16.00% from the prior estimate of $2.86 dated April 1, 2025. The price ...
The 2025 GenScript Virtual Summit—formerly the Gene and Cell Engineering Summit—serves as a leading international forum for scientists, biotech innovators, and pharmaceutical leaders to examine ...
The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science ...
Article ‘Count’ and ‘Share’ for Genscript Biotech Corporation based on listed parameters only. The articles listed below published by authors from Genscript Biotech Corporation, organized by journal ...
PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results